Aberrant expression of glycosylation in juvenile gastrointestinal stromal tumors

Proteomics - Clinical Applications

Volumn 2, Issue 9, 2008, Pages 1246-1254

  Takahashi, Tsuyoshi ^a   Naka, Tetsuji ^b   Fujimoto, Minoru ^b   Serada, Satoshi ^b   Horino, Jirou ^a   Terabe, Fumitaka ^a   Hirota, Seiichi ^c   Miyosh, Eiji ^a   Hirai, Toshihiro ^d   Nakajima, Kiyokazu ^a   Nishitani, Akiko ^e   Souma, Yoshihito ^a   Sawa, Yoshiki ^a   Nishida, Toshirou ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Glycosylation; Juvenile GIST; KIT; Mass spectrometer; ST6Gal1

Indexed keywords

CD34 ANTIGEN; GLYCOPEPTIDASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SIALIC ACID; STEM CELL FACTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; DOWNSTREAM PROCESSING; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; SCHOOL CHILD; SIGNAL TRANSDUCTION; TUMOR VOLUME;

EID: 53549089583     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200700119     Document Type: Article

References (47)

1. Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K. et al., Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998, 279, 577-580.
2. Fishman, A. P., Rosai, J. (Eds.), Gastrointestinal tract. In: Ackerman's Surgical Pathology, Mosby, St Louis 1996, 8th edn., pp.645-647.
3. Kindoblom, L., Remotti, H., Aldenborg, F., Meis-Kindblom, J. M., Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal tumors show phenotypic characteristics of the interstitial cells of Cajar. Am. J. Pathol. 1998, 152, 1259-1269.
4. Taniguchi, M., Nishida, T., Hirota, S., Isozaki, K. et al., Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 1999, 59, 4297-4300.
5. Lasota, J., Jasinski, M., Sarlomo-Rikala, M., Miettinen, M., Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 1999, 154, 53-60.
6. Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K. et al., Familial gastrointestinal stromal tumours with germline mutation of the kit gene. Nat. Genet. 1998, 19, 323-324.
7. Hirota, S., Nishida, T., Isozaki, K., Taniguchi, M. et al., Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 2002, 122, 1493-1499.
8. Isozaki, K., Terris, B., Belghiti, J., Schiffmann, S. et al., Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am. J. Pathol. 2000, 157, 1581-1585.
9. Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L. et al., PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003, 299, 708-710.
10. Hirota, S., Ohashi, A., Nishida, T., Isozaki, A. et al., Gain-of-function mutation of platelet-derived growth factor receptor αgene in gastrtointestinal stromal tumors. Gastroenterology 2003, 125, 660-667.
11. Kinoshita, K., Hirota, S., Isozaki, K., Ohashi, A. et al., Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J. Pathol. 2004, 202, 80-85.
12. Carney, J. A., Sheps, S. G., Go, V. L., Gordon, H., The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. Cancer 1979, 43, 374-382.
13. Diment, J., Tamborini, E., Casali, P., Gronchi, A. et al., Carney triad: case report and molecular analysis of gastric tumor. Hum. Pathol. 2005, 36, 112-116.
14. Prakash, S., Sarran, L., Socci, N., DeMatteo, R P. et al., Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J. Pediatr. Hematol. Oncol. 2005, 7, 179-187.
15. Miettinen, M., Lasota, J., Sobin, L H., Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am. J. Surg. Pathol. 2005, 29, 1373-1381.
16. O'Sullivan, M. J., McCabe, A., Gillett, P., Penman, I. D. et al., Multiple gastric stromal tumors in a child without syndromic association lacks common KIT or PDGFRalpha mutations. Pediatr. Dev. Pathol. 2005, 8, 685-689.
17. Hayashi, Y., Okazaki, T., Yamataka, A., Yanai, T. et al., Gastrointestinal stromal tumor in a child and review of the literature. Pediatr. Surg. Int. 2005, 21, 914-917.
18. DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S. et al., Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann. Surg. 2000, 231, 51-58.
19. Kerr, J. Z., Hicks, M. J., Nuchtern, J. G., Saldivar, V. et. al., Gastrointestinal autonomic nerve tumors in the pediatric population: a report of four cases and a review of the literature. Cancer 1999, 85, 220-230.
20. Hirota, S., Ito, A., Nagoshi, J.,Takeda, M. et al., Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. Lab. Invest. 1995, 72, 64-69.
21. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
22. Hedlund, M., Ng, E., Varki, A., Varki, N. M., Alpha 2-6 linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res. 2008, 68, 388-394.
23. Senda, M., Ito, A., Tsuchida, A., Hagiwara, T. et al., Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GaINAc 2165; in renal cancers. Biochem. J. 2007, 402, 459-470.
24. Schneider, F., Kemmner, W., Haensch, W., Franke, G. et al., Overexpression of sialyltransferase CMP-sialic acid:Galbeta 1,3GalNAc-R alpha 6-sialyltransferase is related to poor patient survival in human colorectal carcinoma. Cancer Res. 2001, 61, 4605-4611.
25. Varki, A., Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3, 97-130.
26. Isaji, T., Gu, J., Nishiuchi, R., Zhao, Y. et al., Introduction of bisecting GIcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J. Biol. Chem. 2004, 279, 19747-19754.
27. Stanley, P. Biological consequences of overexpressing or eliminating N-acetylglucosaminyltransferase-TIII in the mouse. Biochim. Biophys. Acta. 2002, 1573, 363-368.
28. Hakomori, S., Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 1989, 52, 257-331.
29. Tsuda, T., Ikeda, Y., Taniguchi, N., The Asn-420-linked sugar chain in human epidermal growth factor receptor suppresses ligand-independent spontaneous oligomerization. Possible role of a specific sugar chain in controllable receptor activation. J. Biol. Chem. 2000, 275, 21988-21994.
30. Yu, X., Sharma, K. D., Takahashi, T., Iwamoto, R. et al., Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell 2002, 13, 2547-2557.
31. Weinstein, J., de Souza-e-Silva, U., Paulson, J. C., Purification of a Gal beta 1 to 4GIcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GIcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver. J. Biol. Chem. 1982; 257, 13835-13844.
32. Weinstein, J., de Souza-e-Silva, U., Paulson, J. C., Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GIcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GIcNAc alpha 2 to 6 sialyltransferase from rat liver. J. Biol. Chem. 1982, 257, 13845-13853.
33. Dall'Olio, F., Malagolini, N., di Stefano, G., Minni, F. et al., Increased CMP-NeuAc:Gal beta 1,4GIcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues. Int. J. Cancer 1989, 44, 434-439.
34. Dall'Olio, F., Malagolini, N., Serafini-Cessi, F., Enhanced CMP-NeuAc:Gal beta 1,4GIcNAc-R alpha 2,6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft-derived cell lines. Int. J. Cancer 1992, 50, 325-330.
35. Gessner, P., Riedl, S., Quentmaier, A., Kemmner, W., Enhanced activity of CMP-neuAc:Gal beta 1-4GIcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett. 1993, 75, 143-149.
36. Recchi, M. A., Hebbar, M., Hornez, L., Harduin-Lepers, A. et al., Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res. 1998, 58, 4066-4070.
37. Skacel, P. O., Edwards, A. J., Harrison, C. T., Watkins, W. M., Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase. Blood 1991, 78, 1452-1460.
38. Wang, P. H., Li, Y. F., Juang, C. M., Lee, Y. R. et al., Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. Gynecol. Oncol. 2001, 83, 121-127.
39. Kaneko, Y., Yamamoto, H., Kersey, D. S., Colley, K. J. et al., The expression of Gal beta 1,4GIcNAc alpha 2,6 sialyltransferase and alpha 2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol. (Berl) 1996, 91, 284-292.
40. Shibuya, N., Goldstein, I. J., Broekaert, W. F., Nsimba-Lubaki, M. et al., The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J. Biol. Chem. 1987, 262, 1596-1601.
41. Yamashita, K., Fukushima, K., Sakiyama, T., Murata, F. et al., Expression of Sia alpha 2->6Gal beta 1->4GIcNAc residues on sugar chains of glycoproteins including carcinoembryonic antigens in human colon adenocarcinoma: applications of Trichosanthes japonica agglutinin I for early diagnosis. Cancer Res. 1995, 55, 1675-1679.
42. Hennet, T., Chui, D., Paulson, J. C., Marth, J. D., Immune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA 1998, 95, 4504-4509.
43. Peter, M. E., Hellbardt, S., Schwartz-Albiez, R., Westendorp, Mo. et al., Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ. 1995, 2, 163-171.
44. Keppler, O. T., Peter, M. E., Hinderlich, S., Moldenhauer, G. et al., Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/ Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology 1999, 9, 557-569.
45. Lajoie, P., Partridge, E. A., Guay, G., Goetz, J. G. et al., Plasma membrane domain organization regulates EGFR signaling in tumor cells. J. Cell Biol. 2007, 179, 341-356.
46. Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I. et al., Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007, 129, 123-134.
47. Crocker, P. R., Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signaling. Curr. Opin. Struct. Biol. 2002, 12, 609-615.